Zobrazeno 1 - 4
of 4
pro vyhledávání: '"AMPHEUS Project"'
Autor:
Sue Ann Costa Clemens, Pedro M. Folegatti, Katherine R. W. Emary, Lily Yin Weckx, Jeremy Ratcliff, Sagida Bibi, Ana Verena De Almeida Mendes, Eveline Pipolo Milan, Ana Pittella, Alexandre V. Schwarzbold, Eduardo Sprinz, Parvinder K. Aley, David Bonsall, Christophe Fraser, Michelle Fuskova, Sarah C. Gilbert, Daniel Jenkin, Sarah Kelly, Simon Kerridge, Teresa Lambe, Natalie G. Marchevsky, Yama F. Mujadidi, Emma Plested, Maheshi N. Ramasamy, Peter Simmonds, Tanya Golubchik, Merryn Voysey, Andrew J. Pollard, the AMPHEUS Project, Oxford COVID Vaccine Trial Team
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Emerging variants of SARS-CoV-2 raise concerns about vaccine efficiency. Here, the authors present a post-hoc analysis for the ChAdOx1 nCoV-19 (AZD1222) vaccine trial in Brazil and provide efficacy against symptomatic COVID-19 caused by the Zeta (P.2
Externí odkaz:
https://doaj.org/article/2174b542d59f4531bfbfd908fa719572
Autor:
Ratcliff, Jeremy, Al-Beidh, Farah, Bibi, Sagida, Bonsall, David, Costa Clemens, Sue Ann, Estcourt, Lise, Evans, Amy, Fish, Matthew, Folegatti, Pedro M, Gordon, Anthony C, Jay, Cecilia, Jennings, Aislinn, Laing, Emma, Lambe, Teresa, MacIntyre-Cockett, George, Menon, David, Mouncey, Paul R, Nguyen, Dung, Pollard, Andrew J, Ramasamy, Maheshi N, Roberts, David J, Rowan, Kathryn M, Rynne, Jennifer, Shankar-Hari, Manu, Williams, Sarah, Harvala, Heli, Golubchik, Tanya, Simmonds, Peter, AMPHEUS Project, REMAP-CAP Immunoglobulin Domain UK Investigators
Publikováno v:
e0228321
Tools to detect SARS-CoV-2 variants of concern and track the ongoing evolution of the virus are necessary to support public health efforts and the design and evaluation of novel COVID-19 therapeutics and vaccines. Although next-generation sequencing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c09b4c5807f84bf48933315b7d235b
http://hdl.handle.net/10044/1/97284
http://hdl.handle.net/10044/1/97284
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Emary, Katherine RW, Golubchik, Tanya, Aley, Parvinder K, Ariani, Cristina V, Angus, Brian, Bibi, Sagida, Blane, Beth, Bonsall, David, Cicconi, Paola, Charlton, Sue, Clutterbuck, Elizabeth A, Collins, Andrea M, Cox, Tony, Darton, Thomas C, Dold, Christina, Douglas, Alexander D, Duncan, Christopher JA, Ewer, Katie J, Flaxman, Amy L, Faust, Saul N, Ferreira, Daniela M, Feng, Shuo, Finn, Adam, Folegatti, Pedro M, Fuskova, Michelle, Galiza, Eva, Goodman, Anna L, Green, Catherine M, Green, Christopher A, Greenland, Melanie, Hallis, Bassam, Heath, Paul T, Hay, Jodie, Hill, Helen C, Jenkin, Daniel, Kerridge, Simon, Lazarus, Rajeka, Libri, Vincenzo, Lillie, Patrick J, Ludden, Catherine, Marchevsky, Natalie G, Minassian, Angela M, McGregor, Alastair C, Mujadidi, Yama F, Phillips, Daniel J, Plested, Emma, Pollock, Katrina M, Robinson, Hannah, Smith, Andrew, Song, Rinn, Snape, Matthew D, Sutherland, Rebecca K, Thomson, Emma C, Toshner, Mark, Turner, David PJ, Vekemans, Johan, Villafana, Tonya L, Williams, Christopher J, Hill, Adrian VS, Lambe, Teresa, Gilbert, Sarah C, Voysey, Merryn, Ramasamy, Maheshi N, Pollard, Andrew J, COVID-19 Genomics UK Consortium, AMPHEUS Project, Oxford COVID-19 Vaccine Trial Group
BACKGROUND: A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the efficacy of the adenoviral vector vaccine, ChAdOx1 nCoV-19 (AZD1222), against this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c40c9e4ae4e9c5cf3883d824ea7f351
https://www.repository.cam.ac.uk/handle/1810/322058
https://www.repository.cam.ac.uk/handle/1810/322058